Sarcoma treatment aims to remove cancerous tissue, control symptoms, and reduce the risk of the disease returning. The approach depends on the type of sarcoma, its location, and how far it has spread. Standard treatments include surgery, radiation, and chemotherapy, while researchers continue to explore new therapies through clinical trials that may offer hope for patients with difficult-to-treat or advanced disease.

Understanding Treatment Goals and Options

When someone receives a diagnosis of sarcoma, the medical team focuses on several key goals. The first priority is often to remove the cancerous tissue completely, which can prevent the disease from spreading to other parts of the body. For patients where complete removal isn’t possible, treatment aims to control tumor growth, relieve symptoms like pain or difficulty moving, and maintain quality of life as much as possible^[1].

Treatment choices depend heavily on where the sarcoma is located and what type it is. Soft tissue sarcomas, which grow in muscles, fat, blood vessels, or connective tissue, may require different approaches than bone sarcomas, which develop in skeletal structures. The size of the tumor, whether it has spread to lymph nodes or distant organs, and the patient’s overall health all influence the treatment plan^[2].

Medical societies have established guidelines that help doctors determine the most appropriate treatments for each type of sarcoma. These recommendations are based on years of research and clinical experience. At the same time, researchers are constantly testing new therapies in clinical trials to find better ways to treat this complex group of cancers. This means patients may have access to both proven standard treatments and innovative experimental approaches^[8].

Standard Treatment Approaches

Surgery as the Primary Treatment

Surgery represents the cornerstone of sarcoma treatment for most patients. The surgeon’s goal is to remove the entire tumor along with a margin of healthy tissue surrounding it. This margin helps ensure that no cancer cells are left behind. For sarcomas in the arms or legs, surgeons perform what’s called limb-sparing surgery, which removes the tumor while preserving as much function of the limb as possible. This type of operation can be quite extensive, involving removal of muscle, bone, and other tissues^[8].

In some cases, the surgeon may also need to remove nearby lymph nodes if the cancer has spread there. This is particularly important for certain types of sarcomas that are more likely to spread through the lymphatic system. The surgery can leave significant scars and may initially limit movement in the affected area. However, with proper rehabilitation and physical therapy, many patients regain substantial function over time^[15].

When a tumor is located in a position where limb-sparing surgery isn’t possible, amputation may be necessary. While this is a difficult decision for patients, advances in prosthetic technology have greatly improved outcomes. Most people who undergo amputation can learn to use a prosthetic limb within about a year after surgery. Physical therapists work closely with patients to help them adapt and regain mobility^[15].

Radiation Therapy

Radiation therapy uses high-energy beams to kill cancer cells or stop them from growing. For sarcoma patients, radiation may be given before surgery to shrink the tumor, making it easier to remove. It can also be administered after surgery to destroy any remaining cancer cells and reduce the risk of the disease coming back. Research has shown that radiation therapy after surgery significantly lowers the chance of local recurrence^[11].

There are two main types of radiation therapy used for sarcomas. External radiation therapy directs radiation at the tumor from a machine outside the body. This is the most common form and involves daily treatments over several weeks. Internal radiation therapy, also called brachytherapy, involves placing radioactive materials directly into or near the cancer. This allows for a higher dose of radiation to be delivered to a smaller area while limiting exposure to surrounding healthy tissue^[9].

Side effects of radiation therapy can include skin changes in the treated area, similar to a sunburn, as well as fatigue. Over time, radiation can make tissues less flexible and stretchy, which may cause some tightness or discomfort. These effects typically develop gradually and can last for months or years after treatment ends. Patients should discuss these potential long-term effects with their medical team^[15].

Chemotherapy

Chemotherapy involves using drugs to kill cancer cells throughout the body. These medications travel through the bloodstream and can reach cancer cells that have spread beyond the original tumor site. However, chemotherapy is effective for only certain types of sarcomas. It tends to work better for bone sarcomas than for many soft tissue sarcomas^[2].

For bone sarcomas, chemotherapy can significantly improve outcomes and has become a standard part of treatment. The process is lengthy and demanding, typically involving multiple cycles of treatment over several months. While chemotherapy targets cancer cells, it also affects some healthy cells, particularly those that divide rapidly such as cells in the bone marrow, digestive tract, and hair follicles^[3].

Common side effects of chemotherapy include nausea, vomiting, hair loss, fatigue, and increased risk of infection due to low white blood cell counts. Doctors can prescribe medications to help manage many of these side effects. For patients with soft tissue sarcomas that have spread to other organs, chemotherapy may be recommended, although complete responses are relatively rare in these advanced cases^[9].

Targeted Therapy and Immunotherapy

Beyond traditional chemotherapy, newer treatment approaches have emerged. Targeted therapy uses drugs that specifically attack certain molecules involved in cancer cell growth. These treatments tend to cause different side effects than standard chemotherapy because they are more selective in which cells they affect^[13].

One example of an approved targeted therapy for sarcoma is denosumab (Xgeva), which targets a specific pathway called RANKL and is used for certain patients with bone cancer. This drug works by interfering with the signals that allow cancer cells to grow and spread in bone tissue^[10].

Immunotherapy represents another important treatment category. These medications help the body’s own immune system recognize and attack cancer cells. Several immunotherapy drugs have been approved for specific groups of sarcoma patients. These include atezolizumab (Tecentriq), dostarlimab (Jemperli), and pembrolizumab (Keytruda), which are checkpoint inhibitors that target the PD-1/PD-L1 pathway. They work by removing the “brakes” that prevent immune cells from attacking cancer^[10].

These immunotherapy drugs are approved for sarcomas with certain characteristics. For example, pembrolizumab can be used for advanced sarcomas that have high microsatellite instability (MSI-H), DNA mismatch repair deficiency (dMMR), or high tumor mutational burden (TMB-H). These features indicate that the tumor has many genetic changes that make it more visible to the immune system^[10].

Treatment in Clinical Trials

Why Clinical Trials Matter for Sarcoma

Because sarcomas are rare and include more than 70 different subtypes, developing effective treatments requires ongoing research. Many patients with sarcoma, especially those whose cancer has spread or doesn’t respond to standard treatments, may benefit from participating in clinical trials. These studies test new drugs and treatment approaches that could eventually become standard options if proven effective^[11].

Clinical trials are conducted in three main phases. Phase I trials test a new treatment in a small group of people to evaluate its safety and determine the best dose. Phase II trials involve more patients and focus on whether the treatment works against the cancer. Phase III trials compare the new treatment with current standard therapy to see if it offers better results^[9].

Innovative Therapies Under Investigation

Researchers are exploring several promising approaches in clinical trials. One area of intense focus is adoptive cell therapy, a type of immunotherapy where a patient’s own immune cells are collected, modified in the laboratory to better recognize cancer, and then returned to the patient’s body. Studies have shown encouraging results with this approach for certain sarcoma subtypes^[10].

In 2011, researchers at the National Cancer Institute demonstrated that adoptive immunotherapy using genetically engineered T cells could induce tumor regression in patients with synovial sarcoma. The T cells were modified to recognize a protein called NY-ESO-1, which is present on many sarcoma cells. This groundbreaking work showed that the immune system could be harnessed to fight sarcomas that had not responded to other treatments^[10].

Scientists are also testing new combinations of checkpoint inhibitors with other treatments. The idea is that using multiple approaches together might be more effective than any single therapy alone. Some trials are examining whether combining checkpoint inhibitors with targeted therapies or chemotherapy can improve outcomes for patients with advanced sarcoma^[10].

Targeted Molecular Therapies

As researchers learn more about the genetic changes that drive different types of sarcomas, they can develop drugs that target these specific abnormalities. For example, gastrointestinal stromal tumors (GIST), a type of soft tissue sarcoma, often have mutations in genes called KIT or PDGFRA. Drugs that specifically inhibit these proteins have proven highly effective for many patients with GIST^[2].

A clinical trial demonstrated that patients with GIST who received uninterrupted treatment with the targeted drug imatinib had better outcomes than those who stopped treatment. This finding has influenced treatment guidelines and shows how clinical trial results directly improve patient care^[10].

Another exciting development involves drugs targeting growth factor receptors and signaling pathways that cancer cells use to survive and multiply. Researchers are testing various enzyme inhibitors that block specific steps in the processes that cancer cells need to grow. These drugs are designed to be more precise than traditional chemotherapy, potentially offering better effectiveness with fewer side effects^[12].

Novel Approaches and Combination Strategies

Some trials are investigating entirely new treatment concepts. For instance, researchers are studying drugs that affect the tumor’s blood supply. Tumors need a network of blood vessels to grow beyond a certain size, and drugs that prevent new blood vessel formation can essentially starve the tumor^[12].

One recent clinical trial showed that a combination chemotherapy regimen helped people with leiomyosarcoma, a type of sarcoma that grows in smooth muscle tissue, live longer. This demonstrates how refinements in treatment approaches through clinical trials can lead to meaningful improvements in outcomes^[10].

Researchers are also exploring drugs for rare and difficult-to-treat sarcomas. For example, nirogacestat has shown promise for patients with desmoid tumors, which are locally aggressive growths that don’t spread but can cause significant problems by invading surrounding tissues. Results from trials suggest this drug may help slow or stop tumor growth in some patients^[10].

For patients with alveolar soft part sarcoma (ASPS), a very rare subtype, trial results have confirmed the effectiveness of atezolizumab, leading to its approval for this specific indication. This shows how clinical research can provide new options even for the rarest forms of sarcoma^[10].

Access to Clinical Trials

Clinical trials for sarcoma are conducted at major cancer centers across the United States, Europe, and other parts of the world. Patients interested in participating should discuss this option with their medical team. Many specialized sarcoma centers actively enroll patients in multiple trials, giving patients access to cutting-edge treatments that are not yet widely available^[11].

Eligibility for clinical trials depends on various factors including the type and stage of sarcoma, previous treatments received, and overall health status. Some trials specifically seek patients with certain molecular characteristics in their tumors, such as specific genetic mutations. Comprehensive testing of the tumor tissue can help identify which trials might be most appropriate for each patient^[12].

Most Common Treatment Methods

• Surgery
  • Limb-sparing surgery to remove tumors while preserving limb function
  • Removal of tumor with surrounding healthy tissue margin
  • Lymph node removal if cancer has spread
  • Amputation when limb preservation is not possible
• Radiation Therapy
  • External beam radiation delivered from outside the body
  • Internal radiation (brachytherapy) placed near the tumor
  • Given before surgery to shrink tumors
  • Given after surgery to reduce recurrence risk
• Chemotherapy
  • Most effective for bone sarcomas like osteosarcoma and Ewing sarcoma
  • Multiple cycles of treatment over several months
  • Used for metastatic disease to control spread
  • Combination regimens for certain subtypes like leiomyosarcoma
• Targeted Therapy
  • Denosumab (Xgeva) for bone sarcoma targeting RANKL pathway
  • Imatinib and similar drugs for GIST targeting KIT or PDGFRA mutations
  • Drugs targeting specific molecular abnormalities in tumor cells
  • Enzyme inhibitors blocking cancer cell growth signals
• Immunotherapy
  • Atezolizumab (Tecentriq) for alveolar soft part sarcoma
  • Dostarlimab (Jemperli) for sarcomas with dMMR
  • Pembrolizumab (Keytruda) for tumors with MSI-H, dMMR, or TMB-H
  • Adoptive cell therapy using genetically engineered T cells
  • Checkpoint inhibitors that help immune system attack cancer

Living with Treatment and Recovery

Recovery from sarcoma treatment can take considerable time, especially after major surgery. Patients who undergo limb-sparing surgery often need extensive physical therapy to regain strength and mobility. The exercises start soon after surgery and continue for many months. While the process can be challenging, most patients see gradual improvement in their ability to move the affected limb^[15].

Scarring from surgery can be significant, and some patients experience tightness or discomfort in the surgical area, particularly if they also received radiation therapy. These physical changes can affect self-esteem and body image. It’s important for patients to know that the people closest to them will not see them differently as a person. Talking openly with family and friends about these concerns can provide important emotional support^[15].

After completing treatment, patients need regular follow-up appointments for several years. These visits typically include a physical examination to check for any signs of the cancer returning, discussions about symptoms, and imaging tests such as chest X-rays to look for any spread to the lungs. Patients should also monitor themselves between appointments for any concerning changes and report them to their healthcare team promptly^[19].

The fear of cancer recurrence is common and can be emotionally difficult. Support groups provide valuable opportunities for patients to connect with others who understand what they’re going through. Many sarcoma-specific organizations offer both in-person and online support groups where patients can share experiences and coping strategies^[15].